September 4, 2025- Terumo Medical Corporation (TMC) is pleased to announce the official opening of its new, 64,000-square-foot manufacturing facility at the company’s Caguas, Puerto Rico, location. The new facility is designed to meet increasing global demand for Terumo’s ANGIO-SEAL® Vascular Closure Device (VCD), manufactured exclusively in Puerto Rico. A long-time leader in the global market, Terumo’s ANGIO-SEAL Device provides active closure for reliable and rapid hemostasis in patients who have undergone angiographic or interventional procedures. The device – which has been used by healthcare professionals to treat more than 10 million patients worldwide – has also proven to accelerate patient mobility and enable same-day discharge, or the potential for patients to be home for recovery soon after their procedures.
The Caguas location currently employs 375 associates, with approximately 180 jobs to be added in the future. An existing, 22,000-square-foot building will continue to be utilized to support related production and administrative needs, with plans for future renovations.